Table 1

Clinical characteristics of study participants according to diabetes type

Type 1 diabetesType 2 diabetesP
n53560
Sex (% male)*285 (53)24 (40)0.05
Race/ethnicity*<0.0001
    Non-Hispanic white466 (87)20 (33)
    African American27 (5)22 (37)
    Hispanic27 (5)16 (27)
    Other15 (3)2 (3)
Age at CVD visit (years)14.6 ± 3.317.4 ± 2.7<0.0001
Duration of diabetes (years)4.8 (2.4–8.0)3.1 (2.1–4.5)0.0001
A1C (%)8.3 ± 1.57.5 ± 2.70.04
Height (cm)162.5 ± 12.6168.1 ± 12.70.001
Weight (kg)60.2 ± 17.395.9 ± 29.1<0.0001
BMI (kg/m2)22.4 ± 4.533.6 ± 8.7<0.0001
BMI Z score0.6 ± 0.91.7 ± 0.9<0.0001
Waist circumference (cm)76.2 ± 11.9103.9 ± 18.5<0.0001
Total cholesterol (mg/dl)169 ± 32171 ± 350.7
LDL cholesterol (mg/dl)100 ± 26105 ± 300.14
HDL cholesterol (mg/dl)55 ± 1242 ± 10<0.0001
Triglycerides (mg/dl)64 (48–89)99 (72–147)<0.0001
SBP (mmHg)117 ± 11125 ± 11<0.0001
DBP (mmHg)68 ± 773 ± 8<0.0001
Pulse pressure (mmHg)49 ± 852 ± 80.001
Albuminuria (%)*11.210.00.80
BrachD (%/mmHg)6.1 ± 1.25.2 ± 0.9<0.0001
PWV (m/s)5.3 ± 0.86.4 ± 1.3<0.0001
AI75 (%)2.2 ± 10.26.4 ± 9.90.003
  • Data are n (%), means ± SD, or medians (interquartile range). BMI Z score was standardized by age and sex per Centers for Disease Control and Prevention growth charts; waist circumference was measured per National Health and Nutrition Examination Survey III; duration of diabetes indicates duration of diabetes at the time of the CVD visit.

  • *P value from χ2 test.

  • P value from Kruskal-Wallis test.

  • P value from t test.